Longevity and Aging: The Moral Imperative | Carolyn Ringel | TEDxBoston

Quick Overview

Carolyn Ringel argues that longevity and aging research is a moral imperative that requires marshalling societal resources, refuting common ethical objections by framing aging as a deadly disease affecting 100% of people, which, if cured, would yield massive economic and societal benefits.

Key Points: Aging is a universally fatal malady affecting 100% of people, causing cell degradation, vision dimming, muscle wasting, and cognitive decline, killing more people than the height of the COVID pandemic. A Pew Research survey found that only 41% of Americans thought medical treatments slowing aging would be good for society, meaning researchers face a greater than 50% chance their work is viewed negatively. The concern that anti-aging research only benefits the rich is addressed by arguing the solution is expanding access, not withholding treatments, citing the availability of free longevity solutions like good sleep and social networks. The argument that a longer-lived population will deplete resources ignores potential improvements, as agricultural technology already produces more calories per person globally, and respected economists find 10 extra years of lifespan add trillions to GDP. Social structure concerns, like straining retirement systems, are countered by pointing out healthier older people remain productive, such as an 80-year-old surgeon completing 30 more transplants while paying into the system. The existential argument that fighting death is unnatural is false because many accepted medical interventions like antibiotics and pacemakers are also unnatural interventions against disease progression. The speaker concludes that funding aging research is crucial because the root cause of diseases like heart disease, diabetes, and cancer is cells aging badly, making it the highest priority for healthcare spending.

Context: Carolyn Ringel delivers a talk at TEDxBoston addressing the ethical and societal concerns surrounding research into longevity and slowing the aging process. She frames aging not as an inevitable condition but as a universal, deadly disease that warrants the same level of societal focus and funding as other major health crises, contrasting this necessity with public skepticism, as evidenced by a Pew Research survey showing over half of Americans view such research negatively.